Evidence map›Paper›PMID 12134945›Full record

ArticlePharmaceutical research2002

Are MDCK cells transfected with the human MDR1 gene a good model of the human intestinal mucosa?

Fuxing Tang, Kazutoshi Horie, Ronald T Borchardt

Open access · greenAbstract readComparative Study
PubMed Publisher
In one paragraph

Article in Pharmaceutical research, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 212 citations in OpenAlex.

  1. European heart journal open · 2025
    Article
  2. Efficacy andAntimicrobial agents and chemotherapy · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Renal Drug Transporters and Drug Interactions.Clinical pharmacokinetics · 2017
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Fuxing TangDepartment of Pharmaceutical Chemistry, The University of Kansas, Lawrence 66047, USA.
Kazutoshi Horie
Ronald T Borchardt
University of Kansas · US

Funding

CYCLIC PRODRUGS OF OPIOID PEPTIDESR01DA009315 · NIDA · UNIVERSITY OF KANSAS LAWRENCE · PI BORCHARDT, RONALD T · 1995 to 2007
$1.7M
TRANSPORT CHARACTERISTICS OF PEPTIDE MIMETICSR01GM051633 · NIGMS · UNIVERSITY OF KANSAS LAWRENCE · PI BORCHARDT, RONALD T · 1994 to 2003
$884k
NIDA NIH HHS DA09315NIGMS NIH HHS GM51633
6 · The paper itself

Abstract

purposeTo investigate whether Madin-Darby canine kidney cells transfected with the human MDR1 gene (MDCK-MDR1) are a good model of the human intestinal mucosa.

methodsP-glycoprotein (P-gp) expression in Caco-2 cells was compared with P-gp expression in MDCK wild- type (MDCK-WT) and MDCK-MDR1 cells using Western blotting methods. The polarized efflux activities of P-gp(s) in MDCK-MDRI cells, MDCK-WT cells, and Caco-2 cells were compared using digoxin as a substrate. Apparent Michaelis-Menten constants (K(M),Vmax) for the efflux of vinblastine in these three cell lines were determined. Apparent inhibition constants (K(I)) of known substrates/inhibitors of P-gp were determined by measuring their effects on the efflux of digoxin in Caco-2 or MDCK-MDR1 cell monolayers.

resultsMDCK-MDR1 cells expressed higher levels of P-gp compared to Caco-2 and MDCK-WT cells, as estimated by Western blots. Two isoforms of P-gp were expressed in Caco-2 and MDCK cells migrating with molecular weights of 150 kDa and 170 kDa. In MDCK-MDR1 cells, the 150 kDa isoforms appeared to be overexpressed. The MDCK-MDR1 cells exhibited higher polarized efflux of [3H]-digoxin than did Caco-2 and MDCK-WT cells. K(M) values of vinblastine in Caco-2. MDCK-WT, and MDCK-MDR1 cells were 89.2+/-26.1, 24.5+/-1.1, and 252.8+/-134.7 microM, respectively, whereas Vmax values were 1.77+/-0.22, 0.42+/-0.01, and 2.43+/-0.86 pmolcm(-2)s(-1), respectively. Known P-gp substrates/inhibitors showed, in general, lower K(I) values for inhibition of digoxin efflux in Caco-2 cells than in MDCK-MDR1 cells.

conclusionsThese data suggest that the MDCK-MDR1 cells overexpress the 150 kDa isoform of P-gp. MDCK-MDR1 cells are a useful model for screening the P-gp substrate activity of drugs and drug candidates. However, the apparent kinetics constants and affinities of substrates determined in the MDCK-MDR1 cell model may be different than the values obtained in Caco-2 cells. These differences in substrate activity could result from differences in the relative expression levels of total P-gp in Caco-2 and MDCK-MDR1 cells and/or differences in the partitioning of substrates into these two cell membrane bilayers.

Indexed as

AnimalsATP Binding Cassette Transporter, Subfamily B, Member 1Caco-2 CellsCell LineDigoxinDogsDose-Response Relationship, DrugDrug Evaluation, PreclinicalGenes, MDRHumansIntestinal MucosaTransfectionATP Binding Cassette Transporter, Subfamily B, Member 1Digoxin

Identifiers

PMID12134945
OpenAlexW1556464588

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.